Abstract
Background: About 10% of women in childbearing age are positive for thyroid antibodies. The presence of such antibodies has been associated with adverse obstetrical outcomes, in particular miscarriage and pre-term delivery, even though the strength of these associations varies widely from one study to another. Aim: To evaluate from the available data of the literature, the association between thyroid autoimmunity and pre-term delivery. Material and methods: MEDLINE, EMBASE, Cochrane Library search from 1990 to 2010. A combination of key words was used to generate 2 subset of citations, one indexing thyroid antibodies and the other indexing pre-term delivery as adverse outcome. Results: Seven studies, collecting about 23,000 patients were selected. Meta-analysis of the studies showed an association between thyroid autoimmunity and pre-term delivery [odds ratio =1.67 (confidence interval: 1.44–1.94; p<0.001)]. Conclusions: The results of the meta-analysis confirmed the association between thyroid autoimmunity and pre-term delivery. A cause-effect relationship has to be still clarified and interventional studies are required.
Similar content being viewed by others
References
Behrman RE, Butler AS, ed. Insitute of Medicine (US) committee on understanding premature birth and assuring healthy outcomes. Washington DC: National Academies Press US, 2007.
Stagnaro-Green A, Glinoer D. Thyroid autoimmunity and the risk of miscarriage. Best Pract Res Clin Endocrinol Metab 2004, 18: 167–81.
Stagnaro-Green A. Maternal thyroid disease and preterm delivery. J Clin Endocrinol Metab 2009, 94: 21–5.
Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol 2009, 62: e1–34.
Glinoer D, Riahi M, Grün JP, Kinthaert J. Risk of subclinical hypothyroidism in pregnant women with asymptomatic autoimmune thyroid disorders. J Clin Endocrinol Metab 1994, 79: 197–204.
Iijima T, Tada H, Hidaka Y, Mitsuda N, MurataY, Amino N. Effects of autoantibodies on the course of pregnancy and fetal growth. Obstet Gynecol 1997, 90: 364–9.
Ghafoor F, Mansoor M, Malik T, et al. Role of thyroid peroxidase antibodies in the outcome of pregnancy. J Coll Physicians Surg Pak 2006, 16: 468–71.
Negro R, Formoso G, Mangieri T, Pezzarossa A, Dazzi D, Hassan H. Levothyroxine treatment in euthyroid pregnant women with autoimmune thyroid disease: effects on obstetrical complications. J Clin Endocrinol Metab 2006, 91: 2587–91.
Männistö T, Vääräsmäki M, Pouta A, et al. Perinatal outcome of children born to mothers with thyroid dysfunction or antibodies: a prospective population-based cohort study. J Clin Endocrinol Metab 2009, 94: 772–9.
Haddow JE, Cleary-Goldman J, McCain MR, et al; First- and Second-Trimester Risk of Aneuploidy (FaSTER) Research Consortium. Thyroperoxidase and thyroglobulin antibodies in early pregnancy and preterm delivery. Obstet Gynecol 2010, 116: 58–62.
Negro R, Schwartz A, Gismondi R, Tinelli A, Mangieri T, Stagnaro-Green A. Universal screening versus case finding for detection and treatment of thyroid hormonal dysfunction during pregnancy. J Clin Endocrinol Metab 2010, 95: 1699–707.
Moleti M, Lo Presti VP, Mattina F, et al. Gestational thyroid function abnormalities in conditions of mild iodine deficiency: early screening versus continuous monitoring of maternal thyroid status. Eur J Endocrinol 2009, 160: 611–7.
Koch CA, Platt JL T cell recognition and immunity in the fetus and mother. Cell Immunol 2007, 248: 12–7.
Gleicher N. Pregnancy-related cell traffic, microchimerism and autoimmunity: the possibility of reducing autoimmune disease prevalence. Expert Rev Obstet Gynecol 2007, 2: 341–5.
Nelson JL, Hughes KA, Smith AG, Nisperos BB, Branchaud AM, Hansen JA. Maternal-fetal disparity in HLA class II alloantigens and the pregnancy-induced amelioration of rheumatoid arthritis. N Engl J Med 1993, 329: 466–71.
Durkin ET, Jones KA, Rajesh D, Shaaban AF. Early chimerism threshold predicts sustained engraftment and NK-cell tolerance in prenatal allogeneic chimeras. Blood 2008, 112: 5245–53.
Nakamura H, Usa T, Motomura M, et al. Prevalence of interrelated autoantibodies in thyroid diseases and autoimmune disorders. J Endocrinol Invest 2008, 31: 861–5.
Colin IM, Isaac J, Dupret P, Ledant T, D’Hautcourt JL Functional lymphocyte subset assessment of the Th1/Th2 profile in patients with autoimmune thyroiditis by flowcytometric analysis of peripheral lymphocytes. J Biol Regul Homeost Agents 2004, 18: 72–6.
Glinoer D, Riahi M, Grün JP, Kinthaert J. Risk of subclinical hypothyroidism in pregnant women with asymptomatic autoimmune thyroid disorders. J Clin Endocrinol Metab 1994, 79: 197–204.
Aksoy DY, Kerimoglu U, Okur H, et al. Effects of prophylactic thyroid hormone replacement in euthyroid Hashimoto’s thyroiditis. Endocr J 2005, 52: 337–43.
Padberg S, Heller K, Usadel KH, Schumm-Draeger PM. One-year prophylactic treatment of euthyroid Hashimoto’s thyroiditis patients with levothyroxine: is there a benefit? Thyroid 2001, 11: 249–55.
Chiovato L, Marcocci C, Mariotti S, Mori A, Pinchera A. L-thyroxine therapy induces a fall of thyroid microsomal and thyroglobulin antibodies in idiopathic myxedema and in hypothyroid, but not in euthyroid Hashimoto’s thyroiditis. J Endocrinol Invest 1986, 9: 299–305.
Rieu M, Richard A, Rosilio M, et al. Effects of thyroid status on thyroid autoimmunity expression in euthyroid and hypothyroid patients with Hashimoto’s thyroiditis. Clin Endocrinol (Oxf) 1994, 40: 529–35.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Negro, R. Thyroid autoimmunity and pre-term delivery: Brief review and meta-analysis. J Endocrinol Invest 34, 155–158 (2011). https://doi.org/10.1007/BF03347047
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03347047